|
New Delhi, Jan 01: The subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) expert panel on set to recommend approval of Oxford COVID-19 vaccine Covishield for emergency use in India.
The meeting comes a day before the dry run for vaccination will be carried out in all states.
The SII is manufacturing ‘Covishield’ vaccine developed by Oxford University and pharma industry major AstraZeneca. Bharat Biotech partnered with the Indian Council of Medical Research to produce ‘Covaxin’, and Pfizer has asked for time to present its data.
The panel comprising of members from the Central Drugs Standard Control Organisation (CDSCO) had previously met on Wednesday to…
